Exact Mass: 520.4365608

Exact Mass Matches: 520.4365608

Found 165 metabolites which its exact mass value is equals to given mass value 520.4365608, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ginsenoyne A linoleate

8-[3-(Hept-6-en-1-yl)oxiran-2-yl]oct-1-en-4,6-diyn-3-yl (9E,12E)-octadeca-9,12-dienoic acid

C35H52O3 (520.3916242)


Ginsenoyne A linoleate is found in tea. Ginsenoyne A linoleate is isolated from ginseng. Isolated from ginseng. Ginsenoyne A linoleate is found in tea.

   

Chenodeoxycholyllysine

6-Amino-2-[(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}-1-hydroxypentylidene)amino]hexanoate

C30H52N2O5 (520.3876022)


Chenodeoxycholyllysine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholyllysine consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Lysine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholyllysine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholyllysine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Deoxycholyllysine

6-Amino-2-[(4-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}-1-hydroxypentylidene)amino]hexanoate

C30H52N2O5 (520.3876022)


Deoxycholyllysine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholyllysine consists of the bile acid deoxycholic acid conjugated to the amino acid Lysine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholyllysine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholyllysine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Anipamil

2-(3-methoxyphenyl)-2-(3-{[2-(3-methoxyphenyl)ethyl](methyl)amino}propyl)tetradecanenitrile

C34H52N2O2 (520.4028572)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   
   

Cyclostellettamine C

Cyclostellettamine C

C36H60N2 (520.475624)


   

Cyclostellettamine D

Cyclostellettamine D

C36H60N2 (520.475624)


   

N-Benzoyl-cycloprotobuxolin-C

N-Benzoyl-cycloprotobuxolin-C

C34H52N2O2 (520.4028572)


   
   

aglaiabbreviatin F

aglaiabbreviatin F

C32H56O5 (520.4127526)


   
   

Plagiospirolide C

Plagiospirolide C

C35H52O3 (520.3916242)


   

Plagiospirolide D

Plagiospirolide D

C35H52O3 (520.3916242)


   

3alpha-O-acetyl-20,24,25-trihydroxydammarane

3alpha-O-acetyl-20,24,25-trihydroxydammarane

C32H56O5 (520.4127526)


   

Lysine conjugated deoxycholic acid putative

Lysine conjugated deoxycholic acid putative

C30H52N2O5 (520.3876022)


   

Ginsenoyne A linoleate

8-[3-(hept-6-en-1-yl)oxiran-2-yl]oct-1-en-4,6-diyn-3-yl (9E,12E)-octadeca-9,12-dienoate

C35H52O3 (520.3916242)


   

FOH 35:10;O2

Pentatriaconta-20Z,31E-dien-2,4,22,34-tetrayne-1,6,33-triol

C35H52O3 (520.3916242)


   

triton(r) x-100, hydrogenated

triton(r) x-100, hydrogenated

C28H56O8 (520.3974976000001)


   

Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides

Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides

C32H66Cl2+4 (520.4541296)


   
   

[1-hydroxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] acetate

[1-hydroxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] acetate

C33H60O4 (520.449136)


   

[1-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-3-hydroxypropan-2-yl] butanoate

[1-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-3-hydroxypropan-2-yl] butanoate

C33H60O4 (520.449136)


   

[1-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-3-hydroxypropan-2-yl] octanoate

[1-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-3-hydroxypropan-2-yl] octanoate

C33H60O4 (520.449136)


   

[1-hydroxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] hexanoate

[1-hydroxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] hexanoate

C33H60O4 (520.449136)


   

(1-hydroxy-3-octoxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

(1-hydroxy-3-octoxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C33H60O4 (520.449136)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C33H60O4 (520.449136)


   

(1-decoxy-3-hydroxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

(1-decoxy-3-hydroxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C33H60O4 (520.449136)


   

[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] decanoate

[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] decanoate

C33H60O4 (520.449136)


   

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C33H60O4 (520.449136)


   

(1-hydroxy-3-tetradecoxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

(1-hydroxy-3-tetradecoxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C33H60O4 (520.449136)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] (Z)-tetradec-9-enoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] (Z)-tetradec-9-enoate

C33H60O4 (520.449136)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C33H60O4 (520.449136)


   

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] tetradecanoate

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] tetradecanoate

C33H60O4 (520.449136)


   

[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] dodecanoate

[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] dodecanoate

C33H60O4 (520.449136)


   

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate

C33H60O4 (520.449136)


   
   

[3-carboxy-2-[(13Z,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(13Z,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropyl]-trimethylazanium

C32H58NO4+ (520.4365608)


   

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (9Z,12Z)-hexadeca-9,12-dienoate

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (9Z,12Z)-hexadeca-9,12-dienoate

C36H56O2 (520.4280076)


   
   
   
   
   

Fahfa 16:2/17:0

Fahfa 16:2/17:0

C33H60O4 (520.449136)


   

Fahfa 20:2/13:0

Fahfa 20:2/13:0

C33H60O4 (520.449136)


   

Fahfa 13:0/20:2

Fahfa 13:0/20:2

C33H60O4 (520.449136)


   

Fahfa 17:1/16:1

Fahfa 17:1/16:1

C33H60O4 (520.449136)


   

Fahfa 22:2/11:0

Fahfa 22:2/11:0

C33H60O4 (520.449136)


   

Fahfa 15:1/18:1

Fahfa 15:1/18:1

C33H60O4 (520.449136)


   

Fahfa 16:0/17:2

Fahfa 16:0/17:2

C33H60O4 (520.449136)


   

Fahfa 14:0/19:2

Fahfa 14:0/19:2

C33H60O4 (520.449136)


   

Fahfa 14:1/19:1

Fahfa 14:1/19:1

C33H60O4 (520.449136)


   

Fahfa 13:1/20:1

Fahfa 13:1/20:1

C33H60O4 (520.449136)


   

Fahfa 19:1/14:1

Fahfa 19:1/14:1

C33H60O4 (520.449136)


   

Fahfa 12:0/21:2

Fahfa 12:0/21:2

C33H60O4 (520.449136)


   

Fahfa 17:0/16:2

Fahfa 17:0/16:2

C33H60O4 (520.449136)


   

Fahfa 21:2/12:0

Fahfa 21:2/12:0

C33H60O4 (520.449136)


   

Fahfa 16:1/17:1

Fahfa 16:1/17:1

C33H60O4 (520.449136)


   

Fahfa 17:2/16:0

Fahfa 17:2/16:0

C33H60O4 (520.449136)


   

Fahfa 20:1/13:1

Fahfa 20:1/13:1

C33H60O4 (520.449136)


   

Fahfa 11:0/22:2

Fahfa 11:0/22:2

C33H60O4 (520.449136)


   

Fahfa 15:0/18:2

Fahfa 15:0/18:2

C33H60O4 (520.449136)


   

Fahfa 19:2/14:0

Fahfa 19:2/14:0

C33H60O4 (520.449136)


   

Fahfa 18:1/15:1

Fahfa 18:1/15:1

C33H60O4 (520.449136)


   

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-12,15,18,21,24,27,30,33-octaenoic acid

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-12,15,18,21,24,27,30,33-octaenoic acid

C36H56O2 (520.4280076)


   

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C32H56O5 (520.4127526)


   

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C32H56O5 (520.4127526)


   

(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C32H56O5 (520.4127526)


   

(1-hydroxy-3-nonanoyloxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

(1-hydroxy-3-nonanoyloxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C32H56O5 (520.4127526)


   

(1-heptanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

(1-heptanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C32H56O5 (520.4127526)


   
   
   
   
   
   
   
   
   
   
   
   
   

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C32H56O5 (520.4127526)


   

(3-hydroxy-2-tridecanoyloxypropyl) (9E,11E,13E)-hexadeca-9,11,13-trienoate

(3-hydroxy-2-tridecanoyloxypropyl) (9E,11E,13E)-hexadeca-9,11,13-trienoate

C32H56O5 (520.4127526)


   

[3-hydroxy-2-[(E)-tridec-8-enoyl]oxypropyl] (4E,7E)-hexadeca-4,7-dienoate

[3-hydroxy-2-[(E)-tridec-8-enoyl]oxypropyl] (4E,7E)-hexadeca-4,7-dienoate

C32H56O5 (520.4127526)


   

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C32H56O5 (520.4127526)


   

DG(29:3)

DG(11:0_18:3)

C32H56O5 (520.4127526)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(29:3)

TG(12:0(1)_6:0_11:3)

C32H56O5 (520.4127526)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hydroxytetratriacontadienoic acid

Hydroxytetratriacontadienoic acid

C34H64O3 (520.4855194)


   
   

FAHFA 10:0/O-23:2

FAHFA 10:0/O-23:2

C33H60O4 (520.449136)


   

FAHFA 10:1/O-23:1

FAHFA 10:1/O-23:1

C33H60O4 (520.449136)


   

FAHFA 10:2/O-23:0

FAHFA 10:2/O-23:0

C33H60O4 (520.449136)


   

FAHFA 11:0/O-22:2

FAHFA 11:0/O-22:2

C33H60O4 (520.449136)


   

FAHFA 11:1/O-22:1

FAHFA 11:1/O-22:1

C33H60O4 (520.449136)


   

FAHFA 11:2/O-22:0

FAHFA 11:2/O-22:0

C33H60O4 (520.449136)


   

FAHFA 12:0/O-21:2

FAHFA 12:0/O-21:2

C33H60O4 (520.449136)


   

FAHFA 12:1/O-21:1

FAHFA 12:1/O-21:1

C33H60O4 (520.449136)


   

FAHFA 12:2/O-21:0

FAHFA 12:2/O-21:0

C33H60O4 (520.449136)


   

FAHFA 13:0/O-20:2

FAHFA 13:0/O-20:2

C33H60O4 (520.449136)


   

FAHFA 13:1/O-20:1

FAHFA 13:1/O-20:1

C33H60O4 (520.449136)


   

FAHFA 13:2/O-20:0

FAHFA 13:2/O-20:0

C33H60O4 (520.449136)


   

FAHFA 14:0/O-19:2

FAHFA 14:0/O-19:2

C33H60O4 (520.449136)


   

FAHFA 14:1/O-19:1

FAHFA 14:1/O-19:1

C33H60O4 (520.449136)


   

FAHFA 14:2/O-19:0

FAHFA 14:2/O-19:0

C33H60O4 (520.449136)


   

FAHFA 15:0/O-18:2

FAHFA 15:0/O-18:2

C33H60O4 (520.449136)


   

FAHFA 15:1/O-18:1

FAHFA 15:1/O-18:1

C33H60O4 (520.449136)


   

FAHFA 15:2/O-18:0

FAHFA 15:2/O-18:0

C33H60O4 (520.449136)


   

FAHFA 16:0/O-17:2

FAHFA 16:0/O-17:2

C33H60O4 (520.449136)


   

FAHFA 16:1/O-17:1

FAHFA 16:1/O-17:1

C33H60O4 (520.449136)


   

FAHFA 16:2/O-17:0

FAHFA 16:2/O-17:0

C33H60O4 (520.449136)


   

FAHFA 17:0/O-16:2

FAHFA 17:0/O-16:2

C33H60O4 (520.449136)


   

FAHFA 17:1/O-16:1

FAHFA 17:1/O-16:1

C33H60O4 (520.449136)


   

FAHFA 17:2/O-16:0

FAHFA 17:2/O-16:0

C33H60O4 (520.449136)


   

FAHFA 18:0/O-15:2

FAHFA 18:0/O-15:2

C33H60O4 (520.449136)


   

FAHFA 18:1/O-15:1

FAHFA 18:1/O-15:1

C33H60O4 (520.449136)


   

FAHFA 18:2(9Z,12Z)/15O-15:0

FAHFA 18:2(9Z,12Z)/15O-15:0

C33H60O4 (520.449136)


   

FAHFA 18:2/O-15:0

FAHFA 18:2/O-15:0

C33H60O4 (520.449136)


   

FAHFA 19:0/O-14:2

FAHFA 19:0/O-14:2

C33H60O4 (520.449136)


   

FAHFA 19:1/O-14:1

FAHFA 19:1/O-14:1

C33H60O4 (520.449136)


   

FAHFA 19:2(10Z,13Z)/2O-14:0

FAHFA 19:2(10Z,13Z)/2O-14:0

C33H60O4 (520.449136)


   

FAHFA 19:2/O-14:0

FAHFA 19:2/O-14:0

C33H60O4 (520.449136)


   

FAHFA 20:0/O-13:2

FAHFA 20:0/O-13:2

C33H60O4 (520.449136)


   

FAHFA 20:1/O-13:1

FAHFA 20:1/O-13:1

C33H60O4 (520.449136)


   

FAHFA 20:2(11Z,14Z)/3O-13:0

FAHFA 20:2(11Z,14Z)/3O-13:0

C33H60O4 (520.449136)


   

FAHFA 20:2/O-13:0

FAHFA 20:2/O-13:0

C33H60O4 (520.449136)


   

FAHFA 21:0/O-12:2

FAHFA 21:0/O-12:2

C33H60O4 (520.449136)


   

FAHFA 21:1/O-12:1

FAHFA 21:1/O-12:1

C33H60O4 (520.449136)


   

FAHFA 21:2/O-12:0

FAHFA 21:2/O-12:0

C33H60O4 (520.449136)


   

FAHFA 22:0/O-11:2

FAHFA 22:0/O-11:2

C33H60O4 (520.449136)


   

FAHFA 22:1/O-11:1

FAHFA 22:1/O-11:1

C33H60O4 (520.449136)


   

FAHFA 22:2(13Z,16Z)/3O-11:0

FAHFA 22:2(13Z,16Z)/3O-11:0

C33H60O4 (520.449136)


   

FAHFA 22:2/O-11:0

FAHFA 22:2/O-11:0

C33H60O4 (520.449136)


   

FAHFA 23:0/O-10:2

FAHFA 23:0/O-10:2

C33H60O4 (520.449136)


   

FAHFA 23:1/O-10:1

FAHFA 23:1/O-10:1

C33H60O4 (520.449136)


   

FAHFA 23:2/O-10:0

FAHFA 23:2/O-10:0

C33H60O4 (520.449136)


   

FAHFA 24:0/O-9:2

FAHFA 24:0/O-9:2

C33H60O4 (520.449136)


   

FAHFA 24:1/O-9:1

FAHFA 24:1/O-9:1

C33H60O4 (520.449136)


   

FAHFA 24:2/O-9:0

FAHFA 24:2/O-9:0

C33H60O4 (520.449136)


   

FAHFA 25:0/O-8:2

FAHFA 25:0/O-8:2

C33H60O4 (520.449136)


   

FAHFA 25:1/O-8:1

FAHFA 25:1/O-8:1

C33H60O4 (520.449136)


   

FAHFA 25:2/O-8:0

FAHFA 25:2/O-8:0

C33H60O4 (520.449136)


   
   

FAHFA 8:0/O-25:2

FAHFA 8:0/O-25:2

C33H60O4 (520.449136)


   

FAHFA 8:1/O-25:1

FAHFA 8:1/O-25:1

C33H60O4 (520.449136)


   

FAHFA 8:2/O-25:0

FAHFA 8:2/O-25:0

C33H60O4 (520.449136)


   

FAHFA 9:0/O-24:2

FAHFA 9:0/O-24:2

C33H60O4 (520.449136)


   

FAHFA 9:1/O-24:1

FAHFA 9:1/O-24:1

C33H60O4 (520.449136)


   

FAHFA 9:2/O-24:0

FAHFA 9:2/O-24:0

C33H60O4 (520.449136)